Topcon Healthcare, Inc., a global leader in digital health and ocular data solutions, has signed a definitive agreement to acquire Toku, Inc., a San Diego-based artificial intelligence (AI) health technology company originally founded in New Zealand. Toku’s innovative platforms CLAiR™, BioAge™, and MyKidneyAI™ leverage standard color fundus photographs (retinal images) to deliver real-time assessments of cardiovascular risk, biological aging, and chronic kidney disease. Powered by one of the world’s largest retinal-image datasets, these solutions advance Topcon Healthcare’s vision of Healthcare from the Eye™, expanding oculomics to empower primary care and eyecare with preventive medicine.
Read the full article: Topcon Healthcare, Inc. Signs Acquisition Agreement for Toku, Inc. to Expand Fast, Non-Invasive Chronic Disease Screening //
Source: https://topconhealthcare.com/article/topcon-healthcare-inc-signs-acquisition-agreement-for-toku-inc-to-expand-fast-non-invasive-chronic-disease-screening/